UNLV Department of Brain Health

Home
United States
Chicago, IL
UNLV Department of Brain Health

Official account for the Department of Brain Health Kerkorian School of Medicine at UNLV

engagement ≠ endorsement

07/14/2026

📢 Participants Needed!

A brain health grad student in the CANE Lab is recruiting young adults (18–35) for a study on stress & cognitive function at UNLV.

🧠 One in-person lab visit at UNLV

Interested?
Email: [email protected]

07/12/2026

If you're attending , we'd love for you to stop by our poster and chat with us!

Poster: Tuesday-0168
Date & Time: July 14 | 7:30 AM–4:15 PM BST
Poster Title:
Evaluating Methodological Thresholds for Induction-based Cerebral Organoids as Sporadic Alzheimer's Disease Models

If you're in London, come by to learn more about our research and discuss how cerebral organoids can help advance Alzheimer's disease research. We'd love to answer your questions and connect.

07/10/2026

July 10 is .

Did you know that Alzheimer's disease is considered to be a chronic disease. Research shows that other chronic conditions such as diabetes, hypertension, and cardiovascular disease are associated with an increased risk of dementia, including Alzheimer's disease.

07/09/2026

July 10 is .

According to the American Stroke Association up to 80% of strokes may be preventable by managing chronic diseases like high blood pressure, diabetes, and high cholesterol.

Taking care of your body helps protect your brain. ❤️🧠

07/06/2026

July is .

The CANE Lab at UNLV is advancing equitable diagnosis and care for neurodegenerative disorders through inclusive research, community partnerships, and reducing disparities in brain health.

Learn more on their Lab website: https://canelab-unlv.squarespace.com/

07/03/2026

In case you missed it, Dr. Kinney and the Kinney Lab were featured in the Kirk Kerkorian School of Medicine at UNLV Summer Magazine! 🎉

Check out the story on some of our exciting research on page 16: https://university-of-nevada-las-vegas.paperturn-view.com/?pid=ODk8951239&v=3.1

07/02/2026

Dr. Jeffrey Cummings was recently featured on Nevada Week. He discussed the release of the 10th Annual Alzheimer’s Drug Development Pipeline Report.

The report highlights 192 clinical trials testing 158 potential therapies. Dr. Cummings describes this growing pipeline as a “circle of hope” for patients, caregivers, and clinicians working toward more effective Alzheimer’s treatments.

Watch the interview here: https://bit.ly/NevadaWeek-Cummings-CircleOfHope

Read the full report here: https://doi.org/10.1002/trc2.70251

06/30/2026

New research featuring Dr. Cummings identified four existing medications that show promise for treating Alzheimer's disease: atomoxetine, metformin, isosorbide mononitrate, and levetiracetam.

Rather than developing entirely new drugs from scratch, researchers used a rigorous review process to identify medications already approved for other conditions that could potentially be repurposed for Alzheimer's disease. Because these drugs have existing safety data, this approach may help speed up the search for effective and affordable treatments.

Read the study: https://doi.org/10.1002/alz.71495

06/27/2026

New research featuring Dr. Cummings found that repeated head impacts from contact sports may leave small, distinct changes in the brain that can be detected on MRI scans later in life.

Researchers identified a unique pattern of tiny brain lesions in former athletes with a history of repetitive head impacts. These changes were also linked to blood markers associated with brain injury and tau pathology. They may even help researchers better detect and track long-term brain effects related to repeated head trauma.

Read the study: https://doi.org/10.1002/alz.71351

06/24/2026

New research featuring our faculty highlights the growing need for better ways to detect and monitor chronic traumatic encephalopathy (CTE), a brain disease linked to repeated head impacts.

Experts point to promising advances in blood tests, brain imaging, and specialized tau protein markers that could help identify CTE earlier and improve our understanding of how the disease develops over time. These tools may one day support earlier diagnosis, better monitoring, and the development of new treatments for people at risk.

Read the study: https://doi.org/10.1002/alz.71424

Address

2301 S Martin Luther King Dr
Chicago, IL
60616

Website

https://www.unlv.edu/medicine/brain-health

Alerts

Be the first to know and let us send you an email when UNLV Department of Brain Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The University

Send a message to UNLV Department of Brain Health:

Want your university to be the top-listed University in Chicago?